A detailed history of Dark Forest Capital Management LP transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Dark Forest Capital Management LP holds 11,387 shares of CTKB stock, worth $63,767. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,387
Holding current value
$63,767
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$6.29 - $9.15 $71,624 - $104,191
11,387 New
11,387 $76,000
Q1 2023

May 12, 2023

BUY
$8.44 - $13.47 $1.16 Million - $1.86 Million
137,838 New
137,838 $1.27 Million

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $754M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.